Literature DB >> 32202048

Japanese clinical practice guidelines for vascular anomalies 2017.

Hidefumi Mimura1, Sadanori Akita2, Akihiro Fujino3, Masatoshi Jinnin4, Mine Ozaki5, Keigo Osuga6, Hiroki Nakaoka7, Eiichi Morii8, Akira Kuramochi9, Yoko Aoki10, Yasunori Arai1, Noriko Aramaki11, Masanori Inoue12, Yuki Iwashina5, Tadashi Iwanaka13, Shigeru Ueno14, Akihiro Umezawa15, Michio Ozeki16, Junko Ochi17, Yoshiaki Kinoshita18, Masakazu Kurita19, Shien Seike20, Nobuyuki Takakura21, Masataka Takahashi15, Takao Tachibana22, Kumiko Chuman23, Shuji Nagata24, Mitsunaga Narushima25, Yasunari Niimi26, Shunsuke Nosaka27, Taiki Nozaki28, Kazuki Hashimoto1, Ayato Hayashi29, Satoshi Hirakawa30, Atsuko Fujikawa1, Yumiko Hori8, Kentaro Matsuoka31, Hideki Mori7, Yuki Yamamoto4, Shunsuke Yuzuriha32, Naoaki Rikihisa33, Shoji Watanabe34, Shinichi Watanabe35, Tatsuo Kuroda36, Shunsuke Sugawara37, Kosuke Ishikawa38, Satoru Sasaki39.   

Abstract

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence-based medicine (EBM) techniques and aimed at improvement of the outcomes. Clinical questions (CQs) were decided based on the important clinical issues. For document retrieval, key words for literature searches were set for each CQ and literature published from 1980 to the end of September 2014 was searched in Pubmed, Cochrane Library, and Japana Centra Revuo Medicina (JCRM). The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System (MINDS) technique. A total of 33 CQs were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies. This article has been co-published with the permission of The Journal of Dermatology, Pediatrics International and Japanese Journal of Radiology. All rights reserved.
© 2020 The Authors.

Entities:  

Keywords:  clinical practice; guidelines; hemangioma; vascular anomalies; vascular malformation

Year:  2020        PMID: 32202048     DOI: 10.1111/ped.14077

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  2 in total

1.  An unusual cause of proteinuria: lessons for clinical nephrologists.

Authors:  Marina Aksenova; Natalia Zaikova; Andrey Podgorny; Kristina Kostereva
Journal:  J Nephrol       Date:  2022-09-23       Impact factor: 4.393

2.  Severe hypoglycemia in propranolol treatment for infantile hemangiomas.

Authors:  Akira Morimoto; Michio Ozeki; Satoru Sasaki; Naoko Baba; Yoshihiro Kuwano; Tsuyoshi Kaneko
Journal:  Pediatr Int       Date:  2022-01       Impact factor: 1.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.